Elyse Stock
Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
Elyse Stock has filed 5 insider reports with the SEC since November 2021, as officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). Elyse Stock made no open-market purchases or sales in the last 12 months. The latest filing, on October 4, 2022, reports sale back to the company at Biohaven Pharmaceutical Holding Co Ltd. (BHVN).
- Filings
- 5
- Companies
- 1
- Bought on market
- None
- Sold on market
- $3.04M
Companies where Elyse Stock is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer | 0 | $3.04M | $12.39 | Oct 4, 2022 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Oct 3, 2022BHVNSEC Form 4: Stock Elyse returned $2,444,904 worth of shares to the company (16,464 units at $148.50), closing all direct ownership in the company to satisfy withholding taxForm 4Sale back to the company
- Jan 10, 2022BHVNSEC Form 4: Stock Elyse converted options into 937 sharesForm 4Exercise or conversion of a derivative
- Jan 7, 2022BHVNSEC Form 4: Stock Elyse converted options into 9,250 shares and covered exercise/tax liability with 3,377 shares, increasing direct ownership by 49% to 11,090 units (tax liability)Form 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Dec 15, 2021-$3.04MBHVNSEC Form 4: Stock Elyse exercised 28,858 shares at a strike of $14.40 and sold $3,040,889 worth of shares (28,858 units at $105.37) as part of a pre-agreed trading planForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 25, 2021BHVNSEC Form 4: Stock Elyse converted options into 3,375 shares and covered exercise/tax liability with 1,599 shares, increasing direct ownership by 31% to 7,467 units to cover withholding taxForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
Compare Elyse Stock with
- Elyse Stock vs Kimberly Gentile1 shared
- Elyse Stock vs Kishan Mehta1 shared
- Elyse Stock vs Gregory Bailey1 shared
- Elyse Stock vs Michael Thomas Heffernan1 shared
- Elyse Stock vs Irina Antonijevic1 shared
- Elyse Stock vs John W Childs1 shared
Other insiders at the same companies
- Kimberly GentileBHVN
- John YetimogluBHVN
- Warren Karl VollesBHVN
- Kishan MehtaBHVN
- Gregory BaileyBHVN
- Michael Thomas HeffernanBHVN
- Irina AntonijevicBHVN
- John W ChildsBHVN
- Robert J HuginBHVN
- Julia P GregoryBHVN
- Matthew ButenBHVN
- George C. ClarkBHVN
- Bruce CarBHVN
- Vlad CoricBHVN
Questions about Elyse Stock
- What is Elyse Stock's role at Biohaven Pharmaceutical Holding Co Ltd.?
- Elyse Stock reports to the SEC as officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), according to the latest filing on October 4, 2022.
- Has Elyse Stock bought or sold stock recently?
- The most recent open-market sale was on December 15, 2021: sold 28,858 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN) for $3.04M at an average of $105.37.
- How do I get alerts when Elyse Stock files?
- Follow Elyse Stock on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Elyse Stock (SEC CIK 0001785732). Totals count each trade once, skipping amendments whose original is on file, from Nov 26, 2021 on. View on SEC EDGAR · Get this as JSON